Predictive Oncology Inc
POAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.57M
Close$
$0.48
90.1% downside
Current Fair Value
90.1% downsideOvervalued by 90.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.57 Million |
|---|---|
| Enterprise Value | $-1,955,186.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-13.37 |
| Beta | 1.35 |
| Outstanding Shares | 21,184,617 |
Return
| Return on Equity | -567.61% |
|---|---|
| Return on Assets | -505.46% |
| Return on Invested Capital | -583.35% |
Valuation & Multiples
| P/E Ratio | -0.62 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 4.91 |
| Enterprise Value to Revenue | -38.88 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.72 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.95%▼ 18.93% |
|---|---|
| Total Invested | $550,665▼ 49.05% |
| Investors Holding | 140% |
ESG Score
No data
About Predictive Oncology Inc
CEO: Joshua Kornberg